(Total Views: 432)
Posted On: 11/30/2021 7:28:12 PM
Post# of 36563
And there is a recent Nature article about a peptide vaccine inducing T cell response in a phase 1, which was on National news of many countries.
https://www.nature.com/articles/s41586-021-04...mp;amp;amp
This is the kind of result that we could have, with all the media attention. I tried to figure out what could have been wrong for GNBT to fail before the phase 1 but I don’t get it:
- we waited for the second mouse study after the CC, they never presented the results but they sounded optimistic until July
- the final lot of vaccine was about to be ready in the end of June
- they have agreements with Bintai and China for the funding
- the vaccine should be quite stable, I don’t know whether big problems can arise for the GMP
I hope that Zolis Is right and that GNBT can surprise us positively for once…
https://www.nature.com/articles/s41586-021-04...mp;amp;amp
This is the kind of result that we could have, with all the media attention. I tried to figure out what could have been wrong for GNBT to fail before the phase 1 but I don’t get it:
- we waited for the second mouse study after the CC, they never presented the results but they sounded optimistic until July
- the final lot of vaccine was about to be ready in the end of June
- they have agreements with Bintai and China for the funding
- the vaccine should be quite stable, I don’t know whether big problems can arise for the GMP
I hope that Zolis Is right and that GNBT can surprise us positively for once…
(1)
(0)
